Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China

BACKGROUND: Few data exist on the immunogenicity and safety of an inactivated enterovirus 71 vaccine (EV71 vaccine) coadministered with trivalent split-virion inactivated influenza vaccine (IIV3) in infants. METHODS: This trial was a phase 4, randomized, controlled trial. Infants aged 6-11 months we...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yaping, Xiao, Yanhui, Ye, Ying, Jiang, Feng, He, Hanqing, Luo, Linyun, Chen, Haiping, Shi, Lubin, Mu, Qiuyue, Chen, Wei, Guo, Xue, Zhang, Min, Li, Jun, Guan, Qinghu, Chen, Zhiping, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772018/
https://www.ncbi.nlm.nih.gov/pubmed/36569946
http://dx.doi.org/10.3389/fimmu.2022.1080408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772018/
https://www.ncbi.nlm.nih.gov/pubmed/36569946
http://dx.doi.org/10.3389/fimmu.2022.1080408

Ejemplares similares